Pulse Biosciences Statistics
Total Valuation
PLSE has a market cap or net worth of $1.13 billion. The enterprise value is $1.02 billion.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PLSE has 67.27 million shares outstanding. The number of shares has increased by 11.39% in one year.
| Current Share Class | 67.27M |
| Shares Outstanding | 67.27M |
| Shares Change (YoY) | +11.39% |
| Shares Change (QoQ) | +8.17% |
| Owned by Insiders (%) | 73.19% |
| Owned by Institutions (%) | 8.42% |
| Float | 17.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 9.54 |
| P/TBV Ratio | 9.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.58, with a Debt / Equity ratio of 0.07.
| Current Ratio | 15.58 |
| Quick Ratio | 15.37 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -77.86% and return on invested capital (ROIC) is -46.23%.
| Return on Equity (ROE) | -77.86% |
| Return on Assets (ROA) | -43.61% |
| Return on Invested Capital (ROIC) | -46.23% |
| Return on Capital Employed (ROCE) | -50.70% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$803,240 |
| Employee Count | 75 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +125.37% in the last 52 weeks. The beta is 1.60, so PLSE's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | +125.37% |
| 50-Day Moving Average | 16.72 |
| 200-Day Moving Average | 17.79 |
| Relative Strength Index (RSI) | 47.82 |
| Average Volume (20 Days) | 165,995 |
Short Selling Information
The latest short interest is 2.38 million, so 3.54% of the outstanding shares have been sold short.
| Short Interest | 2.38M |
| Short Previous Month | 2.35M |
| Short % of Shares Out | 3.54% |
| Short % of Float | 13.69% |
| Short Ratio (days to cover) | 12.27 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -63.69M |
| Pretax Income | -42.55M |
| Net Income | -60.24M |
| EBITDA | -62.52M |
| EBIT | -63.69M |
| Earnings Per Share (EPS) | -$0.99 |
Full Income StatementBalance Sheet
The company has $119.28 million in cash and $8.58 million in debt, giving a net cash position of $110.70 million or $1.65 per share.
| Cash & Cash Equivalents | 119.28M |
| Total Debt | 8.58M |
| Net Cash | 110.70M |
| Net Cash Per Share | $1.65 |
| Equity (Book Value) | 118.45M |
| Book Value Per Share | 1.76 |
| Working Capital | 113.15M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$40.08 million and capital expenditures -$165,000, giving a free cash flow of -$40.25 million.
| Operating Cash Flow | -40.08M |
| Capital Expenditures | -165,000 |
| Free Cash Flow | -40.25M |
| FCF Per Share | -$0.60 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |